Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05845814
Title A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
Moores Cancer Center ( Site 3028) La Jolla California 92093 United States Details
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 3045) Orange California 92868 United States Details
Anschutz Cancer Pavilion ( Site 3017) Aurora Colorado 80045 United States Details
Emory University School of Medicine ( Site 3043) Atlanta Georgia 30322 United States Details
Indiana University Melvin and Bren Simon Cancer Center ( Site 3011) Indianapolis Indiana 46202 United States Details
Washington University School of Medicine ( Site 3038) Saint Louis Missouri 63110 United States Details
Icahn School of Medicine at Mount Sinai ( Site 3018) New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center ( Site 3031) New York New York 10065 United States Details
Cleveland Clinic-Taussig Cancer Center ( Site 3036) Cleveland Ohio 44195 United States Details
UPMC Hillman Cancer Center ( Site 3014) Pittsburgh Pennsylvania 15232 United States Details
Huntsman Cancer Institute-HCI Clinical Trials Office ( Site 3041) Salt Lake City Utah 84112 United States Details
Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si Brisbane Queensland 4029 Australia Details
Austin Health-Cancer Clinical Trials Centre ( Site 3950) Heidelberg Victoria 3084 Australia Details
The Ottawa Hospital - General Campus-The Ottawa Hospital Cancer Centre ( Site 3105) Ottawa Ontario K1H 8L6 Canada Details
Sunnybrook Research Institute - Odette Cancer Centre ( Site 3108) Toronto Ontario M4N 3M5 Canada Details
Princess Margaret Cancer Centre ( Site 3106) Toronto Ontario M5G 2M9 Canada Details
FALP-UIDO ( Site 3151) Santiago Region M. De Santiago 7500921 Chile Details
Bradfordhill-Clinical Area ( Site 3155) Santiago Region M. De Santiago 8420383 Chile Details
ONCOCENTRO APYS-ACEREY ( Site 3158) Viña del Mar Valparaiso 2520598 Chile Details
Bradford Hill Norte ( Site 3152) Antofagasta 1240000 Chile Details
CHU de Bordeaux Hop St ANDRE ( Site 3607) Bordeaux Aquitaine 33075 France Details
Centre Georges François Leclerc-Centre de recherche clinique ( Site 3608) Dijon Cote-d Or 21079 France Details
Oncopole Claudius Regaud ( Site 3610) Toulouse Haute-Garonne 31059 France Details
Hôpital Européen Georges Pompidou ( Site 3605) Paris Ile-de-France 75015 France Details
centre hospitalier lyon sud ( Site 3606) Pierre-Bénite Rhone 69310 France Details
Rambam Health Care Campus-Oncology Division ( Site 3501) Haifa 3109601 Israel Details
Rabin Medical Center-Oncology ( Site 3504) Petah Tikva 4941492 Israel Details
Sheba Medical Center-ONCOLOGY ( Site 3503) Ramat Gan 5265601 Israel Details
Ospedale San Raffaele-Oncologia Medica ( Site 3403) Milano Lombardia 20132 Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 3405) Milan Lombardia 20133 Italy Details
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 3406) Napoli 80131 Italy Details
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 3903) Seoul 03722 Korea, Republic of Details
Asan Medical Center-Department of Oncology ( Site 3901) Seoul 05505 Korea, Republic of Details
Samsung Medical Center ( Site 3902) Seoul 06351 Korea, Republic of Details
Maastricht UMC+ ( Site 3304) Maastricht Limburg 6229 HX Netherlands Details
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL)-medical oncology ( Site 3302) Amsterdam Noord-Holland 1066 CX Netherlands Details
Erasmus Medisch Centrum-Medical Oncology ( Site 3303) Rotterdam Zuid-Holland 3015 GD Netherlands Details
Hospital Universitari Vall d'Hebron ( Site 3767) Barcelona 08035 Spain Details
Hospital Clinico San Carlos ( Site 3765) Madrid 28040 Spain Details
Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 3802) Kaohsiung 83301 Taiwan Details
National Cheng Kung University Hospital-Clinical Trial Center ( Site 3803) Tainan 704 Taiwan Details
National Taiwan University Hospital-Oncology ( Site 3801) Taipei 10002 Taiwan Details
St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 3206) London London, City Of EC1A 7BE United Kingdom Details
ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 3201) London London, City Of SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from for the field